SCHEMBL1918754

SCHEMBL1918754

CNC(=O)c1cc2cc(OS(=O)(=O)C(F)(F)F)ccc2o1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.52
BCAT1 P54687 1/20 0.50
HSD11B1 P28845 1/20 0.48
TAS1R3 Q7RTX0 9/20 0.47
TAS1R1 Q7RTX1 9/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
FLT3 P36888 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810641 0.86 PIM1 (0.56) PIM1BCAT1HSD11B1TAS1R3TAS1R1
SCHEMBL1936455 0.80 NAMPT (0.39) PIM1BCAT1HSD11B1KDM4EALDH1A1
SCHEMBL7799411 0.76 HSD11B1 (0.49) PIM1HSD11B1TAS1R3TAS1R1KDM4E
SCHEMBL17179765 0.76 PIM1 (0.68) PIM1BCAT1KDM4EALDH1A1GAA
SCHEMBL9989806 0.75 TAS1R3 (0.63) BCAT1TAS1R3TAS1R1CA2
SCHEMBL9989805 0.75 TAS1R3 (0.63) BCAT1TAS1R3TAS1R1CA2
SCHEMBL2370509 0.74 KMT2A (0.48) HSD11B1KDM4EALDH1A1HPGDMEN1
SCHEMBL7799412 0.72 FFAR4 (0.57) PIM1HSD11B1KDM4EALDH1A1CA2
SCHEMBL13724073 0.72 FLT3 (0.67) PIM1TAS1R3TAS1R1KDM4EALDH1A1
SCHEMBL29431703 0.72 KDM4E (0.68) KDM4EALDH1A1GAAHPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed
EP-2326633-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2011-06-01 EP disclosed